Organigram (OGI) Competitors $1.07 +0.03 (+2.88%) Closing price 04:00 PM EasternExtended Trading$1.08 +0.00 (+0.47%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OGI vs. KURA, URGN, MGTX, IMTX, ARVN, SION, CGEM, AKBA, PRTC, and SAGEShould you be buying Organigram stock or one of its competitors? The main competitors of Organigram include Kura Oncology (KURA), UroGen Pharma (URGN), MeiraGTx (MGTX), Immatics (IMTX), Arvinas (ARVN), Sionna Therapeutics (SION), Cullinan Therapeutics (CGEM), Akebia Therapeutics (AKBA), PureTech Health (PRTC), and Sage Therapeutics (SAGE). These companies are all part of the "pharmaceutical products" industry. Organigram vs. Kura Oncology UroGen Pharma MeiraGTx Immatics Arvinas Sionna Therapeutics Cullinan Therapeutics Akebia Therapeutics PureTech Health Sage Therapeutics Kura Oncology (NASDAQ:KURA) and Organigram (NASDAQ:OGI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, community ranking, institutional ownership and media sentiment. Does the media prefer KURA or OGI? In the previous week, Kura Oncology had 1 more articles in the media than Organigram. MarketBeat recorded 2 mentions for Kura Oncology and 1 mentions for Organigram. Organigram's average media sentiment score of 0.84 beat Kura Oncology's score of 0.60 indicating that Organigram is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kura Oncology 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organigram 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is KURA or OGI more profitable? Kura Oncology has a net margin of 0.00% compared to Organigram's net margin of -31.69%. Organigram's return on equity of -8.59% beat Kura Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Kura OncologyN/A -44.09% -39.57% Organigram -31.69%-8.59%-6.54% Which has higher earnings & valuation, KURA or OGI? Organigram has higher revenue and earnings than Kura Oncology. Kura Oncology is trading at a lower price-to-earnings ratio than Organigram, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKura Oncology$53.88M8.84-$152.63M-$2.03-2.91Organigram$166.12M0.81-$33.39M-$0.38-2.82 Do analysts rate KURA or OGI? Kura Oncology presently has a consensus price target of $25.50, indicating a potential upside of 332.20%. Given Kura Oncology's higher possible upside, equities research analysts clearly believe Kura Oncology is more favorable than Organigram.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kura Oncology 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.92Organigram 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in KURA or OGI? Kura Oncology received 238 more outperform votes than Organigram when rated by MarketBeat users. However, 70.71% of users gave Organigram an outperform vote while only 69.65% of users gave Kura Oncology an outperform vote. CompanyUnderperformOutperformKura OncologyOutperform Votes43669.65% Underperform Votes19030.35% OrganigramOutperform Votes19870.71% Underperform Votes8229.29% Do institutionals and insiders hold more shares of KURA or OGI? 34.6% of Organigram shares are owned by institutional investors. 5.5% of Kura Oncology shares are owned by company insiders. Comparatively, 0.1% of Organigram shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, KURA or OGI? Kura Oncology has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Organigram has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. SummaryOrganigram beats Kura Oncology on 10 of the 19 factors compared between the two stocks. Get Organigram News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigramPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$135.09M$6.44B$5.29B$7.35BDividend YieldN/A3.25%5.12%4.31%P/E Ratio-2.826.8821.7117.77Price / Sales0.81231.36379.3997.68Price / CashN/A65.6738.2234.64Price / Book0.585.916.443.98Net Income-$33.39M$142.72M$3.21B$247.44M7 Day Performance10.74%7.98%5.24%4.44%1 Month PerformanceN/A-13.91%-9.49%-7.73%1 Year Performance-41.53%-9.98%11.01%1.28% Organigram Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram0.5255 of 5 stars$1.07+2.9%N/A-44.7%$135.09M$166.12M-2.82860Positive NewsKURAKura Oncology4.1848 of 5 stars$5.76-2.2%$25.50+342.7%-69.1%$465.15M$53.88M-2.44130URGNUroGen Pharma4.3116 of 5 stars$9.96-2.8%$38.20+283.5%-28.3%$459.10M$90.40M-3.16200Analyst ForecastNews CoverageMGTXMeiraGTx4.5849 of 5 stars$5.75+1.2%$24.50+326.1%-1.7%$453.42M$33.28M-4.75300Gap DownHigh Trading VolumeIMTXImmatics2.4839 of 5 stars$3.68+5.1%$16.67+352.9%-60.4%$439.23M$155.84M-5.58260Short Interest ↓News CoverageGap DownHigh Trading VolumeARVNArvinas3.4308 of 5 stars$6.37-2.9%$35.50+457.3%-77.1%$438.08M$263.40M-2.30420Analyst ForecastShort Interest ↓High Trading VolumeSIONSionna TherapeuticsN/A$9.73-2.4%$38.50+295.7%N/A$429.33MN/A0.0035Gap DownCGEMCullinan Therapeutics2.2402 of 5 stars$7.25-2.2%$32.86+353.2%-56.1%$424.22MN/A-2.5530Analyst ForecastNews CoveragePositive NewsAKBAAkebia Therapeutics3.3755 of 5 stars$1.77flat$6.50+267.2%+35.7%$418.13M$160.18M-7.70430PRTCPureTech Health2.8308 of 5 stars$17.30flat$45.00+160.1%-35.3%$415.53M$3.33M0.00100Upcoming EarningsShort Interest ↓High Trading VolumeSAGESage Therapeutics3.8739 of 5 stars$6.66-2.9%$8.81+32.3%-52.8%$409.46M$41.24M-1.01690Analyst Revision Related Companies and Tools Related Companies KURA Competitors URGN Competitors MGTX Competitors IMTX Competitors ARVN Competitors SION Competitors CGEM Competitors AKBA Competitors PRTC Competitors SAGE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OGI) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OGI Stock Free OGI Stock Alerts